Cargando…
Covid-19 and excess mortality in medicare beneficiaries
We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809573/ https://www.ncbi.nlm.nih.gov/pubmed/35108291 http://dx.doi.org/10.1371/journal.pone.0262264 |
_version_ | 1784644046299332608 |
---|---|
author | Greenwald, Scott D. Chamoun, Nassib G. Manberg, Paul J. Gray, Josh Clain, David Maheshwari, Kamal Sessler, Daniel I. |
author_facet | Greenwald, Scott D. Chamoun, Nassib G. Manberg, Paul J. Gray, Josh Clain, David Maheshwari, Kamal Sessler, Daniel I. |
author_sort | Greenwald, Scott D. |
collection | PubMed |
description | We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29, 2020 through September 30, 2020, with mortality followed through November 30(th), 2020. Probable and confirmed Covid-19 diagnoses, presumably mostly symptomatic, were determined from ICD-10 codes. We developed a Risk Stratification Index (RSI) mortality model which was applied prospectively to establish baseline mortality risk. Excess deaths attributable to Covid-19 were estimated by comparing actual-to-expected deaths based on historical (2017–2019) comparisons and in closely matched concurrent (2020) cohorts with and without Covid-19. Overall, 677,100 (2.4%) beneficiaries had confirmed Covid-19 and 2,917,604 (10.3%) had probable Covid-19. A total of 472,329 confirmed cases were community living and 204,771 were in LTC. Mortality following a probable or confirmed diagnosis in the community increased from an expected incidence of about 4.0% to actual incidence of 7.5%. In long-term care facilities, the corresponding increase was from 20.3% to 24.6%. The absolute increase was therefore similar at 3–4% in the community and in LTC residents. The percentage increase was far greater in the community (89.5%) than among patients in chronic care facilities (21.1%) who had higher baseline risk of mortality. The LTC population without probable or confirmed Covid-19 diagnoses experienced 38,932 excess deaths (34.8%) compared to historical estimates. Limitations in access to Covid-19 testing and disease under-reporting in LTC patients probably were important factors, although social isolation and disruption in usual care presumably also contributed. Remarkably, there were 31,360 (5.4%) fewer deaths than expected in community dwellers without probable or confirmed Covid-19 diagnoses. Disruptions to the healthcare system and avoided medical care were thus apparently offset by other factors, representing overall benefit. The Covid-19 pandemic had marked effects on mortality, but the effects were highly context-dependent. |
format | Online Article Text |
id | pubmed-8809573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88095732022-02-03 Covid-19 and excess mortality in medicare beneficiaries Greenwald, Scott D. Chamoun, Nassib G. Manberg, Paul J. Gray, Josh Clain, David Maheshwari, Kamal Sessler, Daniel I. PLoS One Research Article We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29, 2020 through September 30, 2020, with mortality followed through November 30(th), 2020. Probable and confirmed Covid-19 diagnoses, presumably mostly symptomatic, were determined from ICD-10 codes. We developed a Risk Stratification Index (RSI) mortality model which was applied prospectively to establish baseline mortality risk. Excess deaths attributable to Covid-19 were estimated by comparing actual-to-expected deaths based on historical (2017–2019) comparisons and in closely matched concurrent (2020) cohorts with and without Covid-19. Overall, 677,100 (2.4%) beneficiaries had confirmed Covid-19 and 2,917,604 (10.3%) had probable Covid-19. A total of 472,329 confirmed cases were community living and 204,771 were in LTC. Mortality following a probable or confirmed diagnosis in the community increased from an expected incidence of about 4.0% to actual incidence of 7.5%. In long-term care facilities, the corresponding increase was from 20.3% to 24.6%. The absolute increase was therefore similar at 3–4% in the community and in LTC residents. The percentage increase was far greater in the community (89.5%) than among patients in chronic care facilities (21.1%) who had higher baseline risk of mortality. The LTC population without probable or confirmed Covid-19 diagnoses experienced 38,932 excess deaths (34.8%) compared to historical estimates. Limitations in access to Covid-19 testing and disease under-reporting in LTC patients probably were important factors, although social isolation and disruption in usual care presumably also contributed. Remarkably, there were 31,360 (5.4%) fewer deaths than expected in community dwellers without probable or confirmed Covid-19 diagnoses. Disruptions to the healthcare system and avoided medical care were thus apparently offset by other factors, representing overall benefit. The Covid-19 pandemic had marked effects on mortality, but the effects were highly context-dependent. Public Library of Science 2022-02-02 /pmc/articles/PMC8809573/ /pubmed/35108291 http://dx.doi.org/10.1371/journal.pone.0262264 Text en © 2022 Greenwald et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Greenwald, Scott D. Chamoun, Nassib G. Manberg, Paul J. Gray, Josh Clain, David Maheshwari, Kamal Sessler, Daniel I. Covid-19 and excess mortality in medicare beneficiaries |
title | Covid-19 and excess mortality in medicare beneficiaries |
title_full | Covid-19 and excess mortality in medicare beneficiaries |
title_fullStr | Covid-19 and excess mortality in medicare beneficiaries |
title_full_unstemmed | Covid-19 and excess mortality in medicare beneficiaries |
title_short | Covid-19 and excess mortality in medicare beneficiaries |
title_sort | covid-19 and excess mortality in medicare beneficiaries |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809573/ https://www.ncbi.nlm.nih.gov/pubmed/35108291 http://dx.doi.org/10.1371/journal.pone.0262264 |
work_keys_str_mv | AT greenwaldscottd covid19andexcessmortalityinmedicarebeneficiaries AT chamounnassibg covid19andexcessmortalityinmedicarebeneficiaries AT manbergpaulj covid19andexcessmortalityinmedicarebeneficiaries AT grayjosh covid19andexcessmortalityinmedicarebeneficiaries AT claindavid covid19andexcessmortalityinmedicarebeneficiaries AT maheshwarikamal covid19andexcessmortalityinmedicarebeneficiaries AT sesslerdanieli covid19andexcessmortalityinmedicarebeneficiaries |